Any Signature Mapping??? product introduced in the United States may be subject to Food and Drug Administration (???FDA???) review and approval, including with regard to its safety and effectiveness before we may begin marketing and selling any such product in the U.S. Such approval may require us to obtain extensive data from clinical studies to demonstrate such safety or effectiveness.